Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study (Q81364804)
scientific article published on 01 February 2005
Language:
Current Data About Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study
(P31) (Q13442814)
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P304) 548-553
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P407) (Q1860)

(P433) 2
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P478) 52
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P577) Tuesday, February 1, 2005
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P921) (Q861224)
(P887)

(Q422248)
(P887)

(P1433) (Q23929027)
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P1476) "Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study" (language: en)
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P2093) Valeria Gerloni
(P1545) 1
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Irene Pontikaki
(P1545) 2
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Maurizio Gattinara
(P1545) 3
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Francesca Desiati
(P1545) 4
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Elide Lupi
(P1545) 5
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Alfredomaria Lurati
(P1545) 6
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Alessandra Salmaso
(P1545) 7
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

Flavio Fantini
(P1545) 8
(P248)
(P698) 15693004
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15693004%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

other details
description scientific article published on 01 February 2005

External Links
(P356) 10.1002/ART.20793
(P698) 15693004